Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Hepatocellular Carcinoma”

680 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 680 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Study completedNCT02400788
What this trial is testing

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Yakult Honsha Co., LTD 179
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Testing effectiveness (Phase 2)Study completedNCT00524498
What this trial is testing

A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Otsuka Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)UnknownNCT04435977
What this trial is testing

Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocarcinoma
Istituto Clinico Humanitas 46
Testing effectiveness (Phase 2)Study completedNCT01352728
What this trial is testing

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)Looking for participantsNCT06954467
What this trial is testing

JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT03516071
What this trial is testing

Brivanib in Chinese Patients With Previously Treated Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 90
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT03447951
What this trial is testing

PTS100 in Primary HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Gongwin Biopharm Co., Ltd. 33
Testing effectiveness (Phase 2)UnknownNCT01272557
What this trial is testing

Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial

Who this might be right for
Liver Carcinoma
PD Dr. med. Matthias Dollinger 170
Not applicableStudy completedNCT04820712
What this trial is testing

Surgical Therapy and Survival in HCC/ C.F. Zhang et al.

Who this might be right for
Hepatocellular CarcinomaSurgery
Linzhu Zhai 664
Testing effectiveness (Phase 2)Study completedNCT01545804
What this trial is testing

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
National Taiwan University Hospital 55
Testing effectiveness (Phase 2)Study completedNCT01507064
What this trial is testing

Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Cardarelli Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07226063
What this trial is testing

Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Amit Mahipal 16
Testing effectiveness (Phase 2)Study completedNCT03841201
What this trial is testing

Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 50
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT00142467
What this trial is testing

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Massachusetts General Hospital 33
Next Page